Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 24

1.

Calciphylaxis.

Neild GH, Nayer A, Salman L, Asif A.

Clin Kidney J. 2013 Dec;6(6):653-4. doi: 10.1093/ckj/sft110. Epub 2013 Sep 20. No abstract available.

2.

A painful skin rash in a patient with Stage V chronic kidney disease.

Shiell KA, Andrews PA.

NDT Plus. 2011 Jun;4(3):201-4. doi: 10.1093/ndtplus/sfr012. Epub 2011 Mar 15. No abstract available.

3.
4.
5.

Bone marrow blood vessel ossification and "microvascular dead space" in rat and human long bone.

Prisby RD.

Bone. 2014 Jul;64:195-203. doi: 10.1016/j.bone.2014.03.041. Epub 2014 Mar 27.

6.

Calciphylaxis: a review.

Magro CM, Simman R, Jackson S.

J Am Col Certif Wound Spec. 2011 Mar 27;2(4):66-72. doi: 10.1016/j.jcws.2011.03.001. eCollection 2010 Dec. Review.

7.

Painful skin ulcers in a hemodialysis patient.

Sprague SM.

Clin J Am Soc Nephrol. 2014 Jan;9(1):166-73. doi: 10.2215/CJN.00320113. Epub 2013 Nov 7.

8.

Penile calciphylaxis in end stage renal disease.

Barbera V, Di Lullo L, Gorini A, Otranto G, Floccari F, Malaguti M, Santoboni A.

Case Rep Urol. 2013;2013:968916. doi: 10.1155/2013/968916. Epub 2013 Jun 6.

9.

Sodium thiosulfate in the treatment of calciphylaxis.

Cohen GF, Vyas NS.

J Clin Aesthet Dermatol. 2013 May;6(5):41-4.

10.

Major bleeding events and risk stratification of antithrombotic agents in hemodialysis: results from the DOPPS.

Sood MM, Larkina M, Thumma JR, Tentori F, Gillespie BW, Fukuhara S, Mendelssohn DC, Chan K, de Sequera P, Komenda P, Rigatto C, Robinson BM.

Kidney Int. 2013 Sep;84(3):600-8. doi: 10.1038/ki.2013.170. Epub 2013 May 15.

11.

Statin use and calcific uremic arteriolopathy: a matched case-control study.

Nigwekar SU, Bhan I, Turchin A, Skentzos SC, Hajhosseiny R, Steele D, Nazarian RM, Wenger J, Parikh S, Karumanchi A, Thadhani R.

Am J Nephrol. 2013;37(4):325-32. doi: 10.1159/000348806. Epub 2013 Mar 21.

12.

Sodium thiosulfate therapy for calcific uremic arteriolopathy.

Nigwekar SU, Brunelli SM, Meade D, Wang W, Hymes J, Lacson E Jr.

Clin J Am Soc Nephrol. 2013 Jul;8(7):1162-70. doi: 10.2215/CJN.09880912. Epub 2013 Mar 21.

13.

Chemical peritonitis after intraperitoneal sodium thiosulfate.

Gupta DR, Sangha H, Khanna R.

Perit Dial Int. 2012 Mar-Apr;32(2):220-2. doi: 10.3747/pdi.2011.00088. No abstract available.

14.

Bisphosphonate-associated osteonecrosis of the jaw: are we dealing with a localized non-traditional calciphylaxis?

Meiller T, Almubarak H, Weikel D, Brahim J, Scheper M.

Open Dent J. 2012;6:5-7. doi: 10.2174/1874210601206010005. Epub 2012 Jan 12.

15.

Calciphylaxis presenting in early chronic kidney disease with mixed hyperparathyroidism.

Brucculeri M, Haydon AH.

Int J Nephrol Renovasc Dis. 2011;4:157-60. doi: 10.2147/IJNRD.S27607. Epub 2011 Dec 20.

16.

Calcific uremic arteriolopathy in peritoneal dialysis populations.

New N, Mohandas J, John GT, Ratanjee S, Healy H, Francis L, Ranganathan D.

Int J Nephrol. 2011;2011:982854. doi: 10.4061/2011/982854. Epub 2011 Jun 27.

17.

Treatment of severe metastatic calcification and calciphylaxis in dialysis patients.

Goel SK, Bellovich K, McCullough PA.

Int J Nephrol. 2011 Feb 24;2011:701603. doi: 10.4061/2011/701603.

18.

The roles of the skeleton and phosphorus in the CKD mineral bone disorder.

Hruska KA, Mathew S.

Adv Chronic Kidney Dis. 2011 Mar;18(2):98-104. doi: 10.1053/j.ackd.2011.01.001.

19.

Calcific uremic arteriolopathy: pathophysiology, reactive oxygen species and therapeutic approaches.

Sowers KM, Hayden MR.

Oxid Med Cell Longev. 2010 Mar-Apr;3(2):109-21. doi: 10.4161/oxim.3.2.11354. Review.

20.

Breast necrosis: calciphylaxis a rare cause.

Thornton JJ, Dolph J.

Can J Plast Surg. 2008 Fall;16(3):165-7.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk